Growth Metrics

Whitehawk Therapeutics (WHWK) Retained Earnings: 2018-2024

Historic Retained Earnings for Whitehawk Therapeutics (WHWK) over the last 7 years, with Dec 2024 value amounting to -$332.7 million.

  • Whitehawk Therapeutics' Retained Earnings fell 4.96% to -$330.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$330.0 million, marking a year-over-year decrease of 4.96%. This contributed to the annual value of -$332.7 million for FY2024, which is 23.68% down from last year.
  • Per Whitehawk Therapeutics' latest filing, its Retained Earnings stood at -$332.7 million for FY2024, which was down 23.68% from -$269.0 million recorded in FY2023.
  • Whitehawk Therapeutics' Retained Earnings' 5-year high stood at -$32.6 million during FY2020, with a 5-year trough of -$332.7 million in FY2024.
  • For the 3-year period, Whitehawk Therapeutics' Retained Earnings averaged around -$268.3 million, with its median value being -$269.0 million (2023).
  • As far as peak fluctuations go, Whitehawk Therapeutics' Retained Earnings spiked by 77.08% in 2020, and later plummeted by 337.75% in 2021.
  • Whitehawk Therapeutics' Retained Earnings (Yearly) stood at -$32.6 million in 2020, then tumbled by 337.75% to -$142.7 million in 2021, then crashed by 42.41% to -$203.2 million in 2022, then plummeted by 32.36% to -$269.0 million in 2023, then declined by 23.68% to -$332.7 million in 2024.